Clinical trial
NVA237 Versus Placebo 12-week Efficacy Study
NCT01709864
Study timeline
Study start (unknown)2012-11-01Date precision: month
Registry last updated2015-03-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Chronic Obstructive Pulmonary Diseaseunresolved
Interventions
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
MiamiFlorida, United States4Los AngelesCalifornia, United States2San DiegoCalifornia, United States2Las VegasNevada, United States2CharlestonSouth Carolina, United States2DallasTexas, United States1TampaFlorida, United States1CharlotteNorth Carolina, United States1TucsonArizona, United States1Fort LauderdaleFlorida, United States1GreenvilleSouth Carolina, United States1RaleighNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01709864 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.